[{"address1": "11400 West Olympic Boulevard", "address2": "Suite 200", "city": "Los Angeles", "state": "CA", "zip": "90064", "country": "United States", "phone": "310 651 8041", "website": "https://www.immixbio.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Immix Biopharma, Inc., a clinical-stage biopharmaceutical company, engages in the development of chimeric antigen receptor cell therapy in light chain Amyloidosis and immune-mediated diseases in the United States and Australia. The company' lead product is NXC-201 for relapsed/refractory AL Amyloidos. It has a clinical collaboration and supply agreement with BeiGene Ltd. for a combination Phase 1b clinical trial in solid tumors of IMX-110 and anti-PD-1 Tislelizumab. Immix Biopharma, Inc., was incorporated in 2012 and is headquartered in Los Angeles, California.", "fullTimeEmployees": 18, "companyOfficers": [{"maxAge": 1, "name": "Dr. Ilya  Rachman M.B.A., M.D., MBA, Ph.D.", "age": 51, "title": "Co-Founder, CEO & Chairman", "yearBorn": 1973, "fiscalYear": 2024, "totalPay": 712500, "exercisedValue": 0, "unexercisedValue": 120332}, {"maxAge": 1, "name": "Mr. Gabriel  Morris B.A.", "age": 37, "title": "CFO & Director", "yearBorn": 1987, "fiscalYear": 2024, "totalPay": 712500, "exercisedValue": 0, "unexercisedValue": 461582}, {"maxAge": 1, "name": "Dr. Graham  Ross FFPM, M.D.", "age": 64, "title": "Chief Medical Officer & Head of Clinical Development", "yearBorn": 1960, "fiscalYear": 2024, "totalPay": 88593, "exercisedValue": 0, "unexercisedValue": 5100}, {"maxAge": 1, "name": "Mr. Sean  Senn J.D., M.B.A., M.Sc., MBA, MSc", "title": "Co-Founder", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Vladimir P. Torchilin D.Sc., MSE, Ph.D.", "age": 77, "title": "Scientific Co-Founder", "yearBorn": 1947, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. David  Marks MBBS, Ph.D.", "title": "Chief Medical Officer of Cell Therapy", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Gerhard  Bauer", "title": "Head of Cell Therapy Manufacturing", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 2.24, "open": 2.3, "dayLow": 2.05, "dayHigh": 2.31, "regularMarketPreviousClose": 2.24, "regularMarketOpen": 2.3, "regularMarketDayLow": 2.05, "regularMarketDayHigh": 2.31, "payoutRatio": 0.0, "beta": 0.301, "forwardPE": -3.9454546, "volume": 170604, "regularMarketVolume": 170604, "averageVolume": 218335, "averageVolume10days": 109470, "averageDailyVolume10Day": 109470, "bid": 2.09, "ask": 2.19, "bidSize": 3, "askSize": 1, "marketCap": 60493744, "fiftyTwoWeekLow": 1.26, "fiftyTwoWeekHigh": 3.0, "fiftyDayAverage": 2.1125, "twoHundredDayAverage": 1.894845, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 45631568, "profitMargins": 0.0, "floatShares": 18078703, "sharesOutstanding": 27877300, "sharesShort": 246612, "sharesShortPriorMonth": 213578, "sharesShortPreviousMonthDate": 1747267200, "dateShortInterest": 1749772800, "sharesPercentSharesOut": 0.0088, "heldPercentInsiders": 0.40345, "heldPercentInstitutions": 0.122779995, "shortRatio": 0.53, "shortPercentOfFloat": 0.015, "impliedSharesOutstanding": 28976900, "bookValue": 0.344, "priceToBook": 6.3081393, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1743379200, "netIncomeToCommon": -20896912, "trailingEps": -0.69, "forwardEps": -0.55, "enterpriseToEbitda": -2.103, "52WeekChange": 0.023584962, "SandP52WeekChange": 0.12748289, "quoteType": "EQUITY", "currentPrice": 2.17, "targetHighPrice": 7.0, "targetLowPrice": 7.0, "targetMeanPrice": 7.0, "targetMedianPrice": 7.0, "recommendationKey": "none", "numberOfAnalystOpinions": 1, "totalCash": 15921101, "totalCashPerShare": 0.571, "ebitda": -21699388, "totalDebt": 1058943, "quickRatio": 1.711, "currentRatio": 1.803, "debtToEquity": 11.038, "returnOnAssets": -0.50165004, "returnOnEquity": -1.12342, "freeCashflow": -4702446, "operatingCashflow": -12453396, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "IMMX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1639665000000, "postMarketChangePercent": 1.38249, "postMarketPrice": 2.2, "postMarketChange": 0.03, "regularMarketChange": -0.0699999, "regularMarketDayRange": "2.05 - 2.31", "shortName": "Immix Biopharma, Inc.", "longName": "Immix Biopharma, Inc.", "corporateActions": [], "postMarketTime": 1751064229, "regularMarketTime": 1751054400, "exchange": "NCM", "messageBoardId": "finmb_417356223", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": -3.125, "regularMarketPrice": 2.17, "marketState": "CLOSED", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 218335, "fiftyTwoWeekLowChange": 0.9100001, "fiftyTwoWeekLowChangePercent": 0.72222227, "fiftyTwoWeekRange": "1.26 - 3.0", "fiftyTwoWeekHighChange": -0.8299999, "fiftyTwoWeekHighChangePercent": -0.27666664, "fiftyTwoWeekChangePercent": 2.3584962, "earningsTimestamp": 1746734400, "earningsTimestampStart": 1754942400, "earningsTimestampEnd": 1755288000, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -0.69, "epsForward": -0.55, "epsCurrentYear": -0.595, "priceEpsCurrentYear": -3.6470587, "fiftyDayAverageChange": 0.057500124, "fiftyDayAverageChangePercent": 0.027218994, "twoHundredDayAverageChange": 0.27515507, "twoHundredDayAverageChangePercent": 0.14521244, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-12-16", "cryptoTradeable": false, "displayName": "Immix Biopharma", "trailingPegRatio": null, "__fetch_time": "2025-06-28"}]